v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES        
Net income (loss) $ 15,936,368 $ (789,596) $ (2,704,605) $ (1,352,031)
Adjustments to reconcile net loss to net cash used in operating activities:        
Loss on sale of subsidiary 316,343 316,343
Stock based compensation 14,180 69,586 1,264,173 139,173
Imputed interest on loans payable 14,548 14,548 30,082
ROU asset amortization expense 71,459 5,013 10,308 9,893
Depreciation 22,799    
Changes in current assets and liabilities:        
Contract receivable (13,980,386)    
Retention receivable (24,988,055)    
Contract assets (3,033,223)    
Prepaid expense and other current assets 104,877    
Deferred tax asset (3,288,232)    
Right-of-use asset     10,309 9,892
Prepaid assets     12,126 (12,126)
Accounts payable 114,339,829 (16,417) 13,690 18,780
Retention payable 26,810,702    
Accrued payroll (161,086) 208,088 273,183 183,516
Accrued interest 6,000 6,000 12,000 12,000
Accrued interest - related party 44,384    
Contract liabilities (4,353,864)    
Accrued liabilities - related parties (750,000) 50,000 100,000 100,000
Accrued income tax 783,381    
Other liabilities     (16,842)
Operating lease liabilities (71,459) (5,013) (10,309) (9,892)
Other current liabilities 174,731    
Net cash used in operating activities 107,682,405 (141,448) (698,542) (897,448)
CASH FLOWS FROM INVESTING ACTIVITIES        
Cash received in acquisition of TRINITY 13,439,400    
Cash paid for acquisition of TRINITY (1,000,000)    
Collections on note receivable from affiliate 5,267,276    
Cash paid for fixed assets (26,116)    
Net cash provided by investing activities 17,680,560
CASH FLOWS FROM FINANCING ACTIVITIES        
Proceeds from sale of common stock 2,863,750 250,000 750,000 600,000
Future receivables obligation (12,462,502)    
Cash used for principal payments on notes payable (7,538)    
Proceeds from exercise of warrants     250,000
Net cash (used in) provided by financing activities (9,606,290) 250,000 1,000,000 600,000
Net increase in cash and cash equivalents 115,756,675 108,552 301,458 (297,448)
Cash and cash equivalents at beginning of period 328,466 27,008 27,008 324,456
Cash and cash equivalents at end of period 116,085,141 135,560 328,466 27,008
Cash and cash equivalents at end of period - continuing operations 116,085,141   328,466 23,099
Cash and cash equivalents at end of period - discontinued operations     3,909
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:        
Interest paid 3,590,557
Income taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES:        
Common stock issued upon consummation of acquisition 8,400,000    
Note payable issued for acquisition 3,000,000    
Common stock issued to directors for conversion of fees 56,250 150,000 150,000
Payment on debt made by related party directly to lender 3,800,000    
Common stock issued for conversion of loan payable - related party 250,000 250,000
Common stock issued to officers for conversion of salaries $ 180,000 180,000
Establish right-of-use asset and liability     11,255 10,130
Common stock issued from shares to be issued     265
Common stock issued for services     $ 113